世界の肝臓医療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Liver Medicine Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5833 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、肝臓医療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、経口液剤）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・肝臓医療の市場動向 ・企業の競争状況、市場シェア ・肝臓医療の種類別市場規模と予測2016-2027（錠剤、カプセル、経口液剤） ・肝臓医療の用途別市場規模と予測2016-2027（病院、薬局、その他） ・肝臓医療の北米市場規模2016-2027（アメリカ、カナダ） ・肝臓医療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・肝臓医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肝臓医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・肝臓医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Roche、Sanofi、Novartis、Amgen、Xiuzheng Pharmaceutical Group、Xiaolin Zhiyao、Henan Lingrui Pharmaceutical、Kuihua yaoye、Sanjiu Pharmaceutical、Harbin Pharmaceutical Group） ・結論

Liver medicine has a reduced transaminase effect.

Market Analysis and Insights: Global Liver Medicine Market
The global Liver Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liver Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liver Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liver Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liver Medicine market.

Global Liver Medicine Scope and Market Size
Liver Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablet
Capsule
Oral Liquid

Segment by Application
Hospital
Pharmacy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Sanofi
Novartis
Amgen
Xiuzheng Pharmaceutical Group
Xiaolin Zhiyao
Henan Lingrui Pharmaceutical
Kuihua yaoye
Sanjiu Pharmaceutical
Harbin Pharmaceutical Group

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Liquid
1.3 Market by Application
1.3.1 Global Liver Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Liver Medicine Market Perspective (2016-2027)
2.2 Liver Medicine Growth Trends by Regions
2.2.1 Liver Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liver Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Liver Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Liver Medicine Industry Dynamic
2.3.1 Liver Medicine Market Trends
2.3.2 Liver Medicine Market Drivers
2.3.3 Liver Medicine Market Challenges
2.3.4 Liver Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Liver Medicine Players by Revenue
3.1.1 Global Top Liver Medicine Players by Revenue (2016-2021)
3.1.2 Global Liver Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Liver Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liver Medicine Revenue
3.4 Global Liver Medicine Market Concentration Ratio
3.4.1 Global Liver Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Medicine Revenue in 2020
3.5 Liver Medicine Key Players Head office and Area Served
3.6 Key Players Liver Medicine Product Solution and Service
3.7 Date of Enter into Liver Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Medicine Breakdown Data by Type
4.1 Global Liver Medicine Historic Market Size by Type (2016-2021)
4.2 Global Liver Medicine Forecasted Market Size by Type (2022-2027)

5 Liver Medicine Breakdown Data by Application
5.1 Global Liver Medicine Historic Market Size by Application (2016-2021)
5.2 Global Liver Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Liver Medicine Market Size (2016-2027)
6.2 North America Liver Medicine Market Size by Type
6.2.1 North America Liver Medicine Market Size by Type (2016-2021)
6.2.2 North America Liver Medicine Market Size by Type (2022-2027)
6.2.3 North America Liver Medicine Market Size by Type (2016-2027)
6.3 North America Liver Medicine Market Size by Application
6.3.1 North America Liver Medicine Market Size by Application (2016-2021)
6.3.2 North America Liver Medicine Market Size by Application (2022-2027)
6.3.3 North America Liver Medicine Market Size by Application (2016-2027)
6.4 North America Liver Medicine Market Size by Country
6.4.1 North America Liver Medicine Market Size by Country (2016-2021)
6.4.2 North America Liver Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Liver Medicine Market Size (2016-2027)
7.2 Europe Liver Medicine Market Size by Type
7.2.1 Europe Liver Medicine Market Size by Type (2016-2021)
7.2.2 Europe Liver Medicine Market Size by Type (2022-2027)
7.2.3 Europe Liver Medicine Market Size by Type (2016-2027)
7.3 Europe Liver Medicine Market Size by Application
7.3.1 Europe Liver Medicine Market Size by Application (2016-2021)
7.3.2 Europe Liver Medicine Market Size by Application (2022-2027)
7.3.3 Europe Liver Medicine Market Size by Application (2016-2027)
7.4 Europe Liver Medicine Market Size by Country
7.4.1 Europe Liver Medicine Market Size by Country (2016-2021)
7.4.2 Europe Liver Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Liver Medicine Market Size (2016-2027)
8.2 Asia-Pacific Liver Medicine Market Size by Type
8.2.1 Asia-Pacific Liver Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liver Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liver Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Liver Medicine Market Size by Application
8.3.1 Asia-Pacific Liver Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liver Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liver Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Liver Medicine Market Size by Region
8.4.1 Asia-Pacific Liver Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liver Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Liver Medicine Market Size (2016-2027)
9.2 Latin America Liver Medicine Market Size by Type
9.2.1 Latin America Liver Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Liver Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Liver Medicine Market Size by Type (2016-2027)
9.3 Latin America Liver Medicine Market Size by Application
9.3.1 Latin America Liver Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Liver Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Liver Medicine Market Size by Application (2016-2027)
9.4 Latin America Liver Medicine Market Size by Country
9.4.1 Latin America Liver Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Liver Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Liver Medicine Market Size (2016-2027)
10.2 Middle East & Africa Liver Medicine Market Size by Type
10.2.1 Middle East & Africa Liver Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liver Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liver Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Liver Medicine Market Size by Application
10.3.1 Middle East & Africa Liver Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liver Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liver Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Liver Medicine Market Size by Country
10.4.1 Middle East & Africa Liver Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liver Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Liver Medicine Introduction
11.1.4 Pfizer Revenue in Liver Medicine Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Liver Medicine Introduction
11.2.4 Roche Revenue in Liver Medicine Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Liver Medicine Introduction
11.3.4 Sanofi Revenue in Liver Medicine Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Liver Medicine Introduction
11.4.4 Novartis Revenue in Liver Medicine Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Liver Medicine Introduction
11.5.4 Amgen Revenue in Liver Medicine Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Xiuzheng Pharmaceutical Group
11.6.1 Xiuzheng Pharmaceutical Group Company Details
11.6.2 Xiuzheng Pharmaceutical Group Business Overview
11.6.3 Xiuzheng Pharmaceutical Group Liver Medicine Introduction
11.6.4 Xiuzheng Pharmaceutical Group Revenue in Liver Medicine Business (2016-2021)
11.6.5 Xiuzheng Pharmaceutical Group Recent Development
11.7 Xiaolin Zhiyao
11.7.1 Xiaolin Zhiyao Company Details
11.7.2 Xiaolin Zhiyao Business Overview
11.7.3 Xiaolin Zhiyao Liver Medicine Introduction
11.7.4 Xiaolin Zhiyao Revenue in Liver Medicine Business (2016-2021)
11.7.5 Xiaolin Zhiyao Recent Development
11.8 Henan Lingrui Pharmaceutical
11.8.1 Henan Lingrui Pharmaceutical Company Details
11.8.2 Henan Lingrui Pharmaceutical Business Overview
11.8.3 Henan Lingrui Pharmaceutical Liver Medicine Introduction
11.8.4 Henan Lingrui Pharmaceutical Revenue in Liver Medicine Business (2016-2021)
11.8.5 Henan Lingrui Pharmaceutical Recent Development
11.9 Kuihua yaoye
11.9.1 Kuihua yaoye Company Details
11.9.2 Kuihua yaoye Business Overview
11.9.3 Kuihua yaoye Liver Medicine Introduction
11.9.4 Kuihua yaoye Revenue in Liver Medicine Business (2016-2021)
11.9.5 Kuihua yaoye Recent Development
11.10 Sanjiu Pharmaceutical
11.10.1 Sanjiu Pharmaceutical Company Details
11.10.2 Sanjiu Pharmaceutical Business Overview
11.10.3 Sanjiu Pharmaceutical Liver Medicine Introduction
11.10.4 Sanjiu Pharmaceutical Revenue in Liver Medicine Business (2016-2021)
11.10.5 Sanjiu Pharmaceutical Recent Development
11.11 Harbin Pharmaceutical Group
11.11.1 Harbin Pharmaceutical Group Company Details
11.11.2 Harbin Pharmaceutical Group Business Overview
11.11.3 Harbin Pharmaceutical Group Liver Medicine Introduction
11.11.4 Harbin Pharmaceutical Group Revenue in Liver Medicine Business (2016-2021)
11.11.5 Harbin Pharmaceutical Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Liver Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablet
Table 3. Key Players of Capsule
Table 4. Key Players of Oral Liquid
Table 5. Global Liver Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Liver Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Liver Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Liver Medicine Market Share by Regions (2016-2021)
Table 9. Global Liver Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Liver Medicine Market Share by Regions (2022-2027)
Table 11. Liver Medicine Market Trends
Table 12. Liver Medicine Market Drivers
Table 13. Liver Medicine Market Challenges
Table 14. Liver Medicine Market Restraints
Table 15. Global Liver Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Liver Medicine Market Share by Players (2016-2021)
Table 17. Global Top Liver Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Medicine as of 2020)
Table 18. Ranking of Global Top Liver Medicine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Liver Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Liver Medicine Product Solution and Service
Table 22. Date of Enter into Liver Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Liver Medicine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Liver Medicine Revenue Market Share by Type (2016-2021)
Table 26. Global Liver Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Liver Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Liver Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Liver Medicine Revenue Market Share by Application (2016-2021)
Table 30. Global Liver Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Liver Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Liver Medicine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Liver Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Liver Medicine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Liver Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Liver Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Liver Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Liver Medicine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Liver Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Liver Medicine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Liver Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Liver Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Liver Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Liver Medicine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Liver Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Liver Medicine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Liver Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Liver Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Liver Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Liver Medicine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Liver Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Liver Medicine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Liver Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Liver Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Liver Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Liver Medicine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Liver Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Liver Medicine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Liver Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Liver Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Liver Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Liver Medicine Product
Table 65. Pfizer Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Liver Medicine Product
Table 70. Roche Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Liver Medicine Product
Table 75. Sanofi Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Liver Medicine Product
Table 80. Novartis Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Liver Medicine Product
Table 85. Amgen Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 86. Amgen Recent Development
Table 87. Xiuzheng Pharmaceutical Group Company Details
Table 88. Xiuzheng Pharmaceutical Group Business Overview
Table 89. Xiuzheng Pharmaceutical Group Liver Medicine Product
Table 90. Xiuzheng Pharmaceutical Group Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 91. Xiuzheng Pharmaceutical Group Recent Development
Table 92. Xiaolin Zhiyao Company Details
Table 93. Xiaolin Zhiyao Business Overview
Table 94. Xiaolin Zhiyao Liver Medicine Product
Table 95. Xiaolin Zhiyao Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 96. Xiaolin Zhiyao Recent Development
Table 97. Henan Lingrui Pharmaceutical Company Details
Table 98. Henan Lingrui Pharmaceutical Business Overview
Table 99. Henan Lingrui Pharmaceutical Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 100. Henan Lingrui Pharmaceutical Recent Development
Table 101. Kuihua yaoye Company Details
Table 102. Kuihua yaoye Business Overview
Table 103. Kuihua yaoye Liver Medicine Product
Table 104. Kuihua yaoye Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 105. Kuihua yaoye Recent Development
Table 106. Sanjiu Pharmaceutical Company Details
Table 107. Sanjiu Pharmaceutical Business Overview
Table 108. Sanjiu Pharmaceutical Liver Medicine Product
Table 109. Sanjiu Pharmaceutical Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 110. Sanjiu Pharmaceutical Recent Development
Table 111. Harbin Pharmaceutical Group Company Details
Table 112. Harbin Pharmaceutical Group Business Overview
Table 113. Harbin Pharmaceutical Group Liver Medicine Product
Table 114. Harbin Pharmaceutical Group Revenue in Liver Medicine Business (2016-2021) & (US$ Million)
Table 115. Harbin Pharmaceutical Group Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Medicine Market Share by Type: 2020 VS 2027
Figure 2. Tablet Features
Figure 3. Capsule Features
Figure 4. Oral Liquid Features
Figure 5. Global Liver Medicine Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Pharmacy Case Studies
Figure 8. Others Case Studies
Figure 9. Liver Medicine Report Years Considered
Figure 10. Global Liver Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Liver Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Liver Medicine Market Share by Regions: 2020 VS 2027
Figure 13. Global Liver Medicine Market Share by Regions (2022-2027)
Figure 14. Global Liver Medicine Market Share by Players in 2020
Figure 15. Global Top Liver Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Medicine as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Liver Medicine Revenue in 2020
Figure 17. Global Liver Medicine Revenue Market Share by Type (2016-2021)
Figure 18. Global Liver Medicine Revenue Market Share by Type (2022-2027)
Figure 19. North America Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Liver Medicine Market Share by Type (2016-2027)
Figure 21. North America Liver Medicine Market Share by Application (2016-2027)
Figure 22. North America Liver Medicine Market Share by Country (2016-2027)
Figure 23. United States Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Liver Medicine Market Share by Type (2016-2027)
Figure 27. Europe Liver Medicine Market Share by Application (2016-2027)
Figure 28. Europe Liver Medicine Market Share by Country (2016-2027)
Figure 29. Germany Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Liver Medicine Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Liver Medicine Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Liver Medicine Market Share by Region (2016-2027)
Figure 39. China Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Liver Medicine Market Share by Type (2016-2027)
Figure 47. Latin America Liver Medicine Market Share by Application (2016-2027)
Figure 48. Latin America Liver Medicine Market Share by Country (2016-2027)
Figure 49. Mexico Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Liver Medicine Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Liver Medicine Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Liver Medicine Market Share by Country (2016-2027)
Figure 55. Turkey Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Liver Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 63. Xiuzheng Pharmaceutical Group Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 64. Xiaolin Zhiyao Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 65. Henan Lingrui Pharmaceutical Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 66. Kuihua yaoye Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 67. Sanjiu Pharmaceutical Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 68. Harbin Pharmaceutical Group Revenue Growth Rate in Liver Medicine Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---